June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Progressive Corneal Edema and Loss of the Antioxidant lncRNA Neat1 in a Novel Slc4a11 +/W214S Mouse Model of Late-Onset Fuchs Endothelial Corneal Dystrophy
Author Affiliations & Notes
  • Mark Parker
    Physiology and Biophysics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
    Ophthalmology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
  • Sangita P Patel
    Ophthalmology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
    Research Service, VA Western New York Healthcare System, Buffalo, New York, United States
  • Aniko Marshall
    Physiology and Biophysics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
  • Bianca Quade
    Physiology and Biophysics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
    Medicine, Duke University School of Medicine, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Mark Parker None; Sangita Patel None; Aniko Marshall None; Bianca Quade None
  • Footnotes
    Support  NIH Grant EY028580
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 507. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mark Parker, Sangita P Patel, Aniko Marshall, Bianca Quade; Progressive Corneal Edema and Loss of the Antioxidant lncRNA Neat1 in a Novel Slc4a11 +/W214S Mouse Model of Late-Onset Fuchs Endothelial Corneal Dystrophy. Invest. Ophthalmol. Vis. Sci. 2023;64(8):507.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : There are currently no genetic models of late-onset Fuchs Endothelial Corneal Dystrophy (FECD), a complex disease of corneal edema and endothelial guttae which causes vision loss from the fifth decade of life. Such a mouse would be valuable to follow preclinical events, identify biomarkers, and test therapeutic interventions. We recreated, in mice, the heterozygous SLC4A11/W240S mutation (equivalent to W214S in the mouse protein) which causes late-onset FECD in humans.

Methods : We backcrossed Slc4a11+/W214S mice to >99% isogeny with 129S wild-type (WT) mice. Corneal thickness (CT) was monitored bimonthly by ultrasonic pachymetry for 1 year in a cohort of 12 WT and 20 Slc4a11+/W214S mice. At the end of the trial, RNA was prepared from whole eyes from 4 female Slc4a11+/W214S mice and 3 female WT mice. RNA was evaluated by RNA sequencing and differential gene expression analysis (Azenta Life Sciences).

Results : The CT of WT and Slc4a11+/W214S mice was not different at 2, 4, or 6 months (P>0.05), but was significantly thicker in Slc4a11+/W214S mice than in WT mice at 8, 10, and 12 months (P<0.01). At 12 months, the average CT ± SD was 122 ± 4 µm for WT mice (n=12) and 130 ± 6 µm for Slc4a11+/W214S mice (n=18). Of the 17,400 genes identified by RNAseq, only 11 were significantly downregulated in Slc4a11+/W214S mice. The most significantly and robustly altered gene in this set was the antioxidant long non-coding RNA Neat1 (log2foldchange = −1.3, padj = 2x10-6).

Conclusions : Slc4a11+/W214S mice exhibit a progressive increase in CT consistent with late-onset FECD, perhaps at least in part directly due to loss of endothelial pump function caused by Slc4a11 insufficiency. However, the additional loss of Neat1 suggests an unexpected mechanism by which expressivity of late-onset FECD can be influenced by external factors, particularly oxidative damage. The work of others tells us two important things: [1] UVA exposure is sufficient to induce all signs of FECD including guttae (Liu et al., PNAS, 2020) and [2] Neat1 protects corneas from UVA-induced FECD (Wang et al., Mol Ther Nucleic Acids, 2022). Thus, the loss of Neat1 in Slc4a11+/W214S mice suggests that late onset of FECD in the proband with the SLC4A11/W240S mutation may be a combined consequence of SLC4A11 insufficiency as well as reduced protection from UVA-induced corneal damage.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×